Stay updated on Deucravacitinib Safety/Efficacy in Psoriasis Clinical Trial

Sign up to get notified when there's something new on the Deucravacitinib Safety/Efficacy in Psoriasis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Deucravacitinib Safety/Efficacy in Psoriasis Clinical Trial page

  1. Check
    10 days ago
    No Change Detected
  2. Check
    17 days ago
    Change Detected
    Summary
    The page adds a recruitment-status notice and new user guidance sections, along with a UI revision note indicating the version change.
    Difference
    0.1%
    Check dated 2026-06-12T00:29:00.000Z thumbnail image
  3. Check
    24 days ago
    Change Detected
    Summary
    The page revision label was updated to v3.5.5, replacing the previous v3.5.4. This indicates a version update of the page content rather than changes to the study details.
    Difference
    0.0%
    Check dated 2026-06-05T00:40:58.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    The page's revision tag has been updated to v3.5.4, replacing the previous v3.5.3. This reflects a small, non-content-related update to the page version.
    Difference
    0.0%
    Check dated 2026-05-21T17:46:24.000Z thumbnail image
  5. Check
    60 days ago
    Change Detected
    Summary
    The page shows a new Revision: v3.5.3, replacing the previous Revision: v3.5.2, indicating a content update.
    Difference
    0.0%
    Check dated 2026-04-30T08:48:44.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.0 to v3.5.2 on the page.
    Difference
    0.0%
    Check dated 2026-04-15T22:09:38.000Z thumbnail image
  7. Check
    96 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-25T06:59:28.000Z thumbnail image

Stay in the know with updates to Deucravacitinib Safety/Efficacy in Psoriasis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Deucravacitinib Safety/Efficacy in Psoriasis Clinical Trial page.